GL1X · GenesisL1 explorer

MolNFT v1 · #108218 · protein

FGFR1 in complex with AZD4547.

4V05 · Fibroblast growth factor receptor 1 (fms-related tyrosine…: “FGFR1 in complex with AZD4547.”. X-ray diffraction, 2 ligands (66T, SO4), 5 pockets (best druggability 0.74). MolNFT v1 #108218 on GenesisL1: 3D structure, binding sites…

PDB
4V05
Type
protein
Length
573 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, pfeiffer syndrome)…
UniProt
D3DSX2
Ligands
66T, SO4
Pockets
5 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 39% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AFibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, pfeiffer syndrome), isoform CRA_Bprotein28739% helix, 14% strandD3DSX2
BFibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, pfeiffer syndrome), isoform CRA_Bprotein28640% helix, 14% strandD3DSX2

Ligands and binding sites

  • 66T · N-{3-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-5-yl}-4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]benzamide · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 4 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 5 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18460.740.7883empty
24940.710.815766T, SO4
34720.700.8061EDO, 66T, SO4
4860.350.7518empty
5610.300.7413empty

Interfaces

1 interface between chains.

  • A–B · 450 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 4V05 · FGFR1 in complex with AZD4547. · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.